Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy

Human Reproduction

Volumn 21, Issue 8, 2006, Pages 2180-2184

  Väisänen Tommiska, Mervi ^a   Butzow, Ralf ^a   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antiprogestin; Cervical ripening; eNOS; iNOS; Nitrate; Nitrite

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MIFEPRISTONE; NITRIC OXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METABOLITE; PREGNANCY; PROTEIN EXPRESSION; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX MUCUS; UTERINE CERVIX RIPENING; WESTERN BLOTTING;

EID: 33747880399     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del141     Document Type: Article

References (30)

1. Al-Hijji J, Larsson I and Batra S (2001) Effect of ovarian steroids on nitric oxide synthase in the rat uterus, cervix and vagina. Life Sci 69,1133-1142.
2. Ali M, Buhimschi I, Chwalisz K and Garfield RE (1997) Changes in expression of the nitric oxide synthase isoforms in rat uterus and cervix during pregnancy and parturition. Mol Hum Reprod 3,995-1003.
3. Arteaga-Troncoso G, Villegas-Alvarado A, Belmont-Gomez A, Martinez-Herrera FJ, Villagrana-Zesati R and Guerra-Infante F (2005) Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: A randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception. BJOG 112 (12),1615-1619.
4. Batra S, Iosif C, Al-Hijji J and Larsson I (2003) Important differences in nitric oxide synthase activity and predominant isoform in reproductive tissues from human and rat. Reprod Biol Endocrinol 1,10.
5. Ben-Chetrit A, Eldar-Geva T, Lindenberg T, Farhat M, Shimonovitz S, Zacut D, Gelber H, Sitruk-Ware R and Spitz IM (2004) Mifepristone does not induce cervical softening in non-pregnant women. Hum Reprod 19,2372-2376.
6. Brune B, von Knethen A and Sandau KB (1998) Nitric oxide and its role in apoptosis. Eur J Pharmacol 351,261-272.
7. Chia KV and Ogbo VI (2002) Medical termination of missed abortion. J Obstet Gynaecol 22,184-186.
8. Chwalisz K and Garfield RE (1997) Regulation of the uterus and cervix during pregnancy and labor. Role of progesterone and nitric oxide. Ann NY Acad Sci 828,238-253.
9. Chwalisz K, Shao-Qing S, Garfield RE and Beier HM (1997) Cervical ripening in guinea-pigs after a local application of nitric oxide. Hum Reprod 12,2093-2101.
10. Denison FC, Riley SC, Elliott CL, Kelly RW, Calder AA and Critchley HO (2000) The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. Mol Hum Reprod 6,541-548.
11. Ekerhovd E, Bullarbo M, Andersch B and Norstrom A (2003) Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: A randomized controlled study. Am J Obstet Gynecol 189,1692-1697.
12. Hapangama DK, Critchley HO, Henderson TA and Baird DT (2002) Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium. J Clin Endocrinol Metab 87,5229-5234.
13. Hausman N, Beharry KDBS, Nishihara KCBA, Akmal YBS and Asrat T (2003) Effect of the antenatal administration of celecoxib during the second and third trimesters of pregnancy on prostaglandin, cytokine, and nitric oxide levels in rabbits. Am J Obstet Gynecol 189,1737-1743.
14. Heikinheimo O, Tevilin M, Shoupe D, Croxatto H and Lahteenmaki P (1986) Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography. Contraception 34,613-624.
15. Kelly RW (2002) Inflammatory mediators and cervical ripening. J Reprod Immunol 57,217-224.
16. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN and Campana A (2004) Medical methods for first trimester abortion. Cochrane Database Syst Rev (4),CD002855.
17. Ledingham MA, Thomson AJ, Young A, Macara LM, Greer IA and Norman JE (2000) Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod 6,1041-1048.
18. Marx SG, Wentz MJ, Mackay LB, Schlembach D, Maul H, Fittkow C, Given R, Vedernikov Y, Saade GR and Garfield RE (in press) Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix. J Histochem Cytochem.
19. Maul H, Longo M, Saade GR and Garfield RE (2003) Nitric oxide and its role during pregnancy: From ovulation to delivery. Curr Pharm Des 9,359-380.
20. Mitchell LM, Kennedy CR and Hartshorne GM (2004) Expression of nitric oxide synthase and effect of substrate manipulation of the nitric oxide pathway in mouse ovarian follicles. Hum Reprod 19,30-40.
21. Olive DL (2002) Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health. Obstet Gynecol Surv 57,S55-S63.
22. Sennstrom MB, Ekman G, Westergren-Thorsson G, Malmstrom A, Bystrom B, Endresen U, Mlambo N, Norman M, Stabi B and Brauner A (2000) Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod 6,375-381.
23. Shaamash AH and Zakhari MM (2005) Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding. Hum Reprod 20,302-306.
24. Stjernholm-Vladic Y, Stygar D, Mansson C, Masironi B, Akerberg S, Wang H, Ekman-Ordeberg G and Sahlin L (2004a) Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol 2,74.
25. Stjernholm-Vladic Y, Wang H, Stygar D, Ekman G and Sahlin L (2004b) Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol 18,41-46.
26. Tschugguel W, Schneeberger C, Lass H, Stonek F, Zaghlula MB, Czerwenka K, Schatten C, Kaider A, Husslein P and Huber JC (1999) Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod 60,1367-1372.
27. Väisänen-Tommiska M, Nuutila M, Aittomaki K, Hiilesmaa V and Ylikorkala O (2003) Nitric oxide metabolites in cervical fluid during pregnancy: Further evidence for the role of cervical nitric oxide in cervical ripening. Am J Obstet Gynecol 188,779-785.
28. Väisänen-Tommiska M, Mikkola TS and Ylikorkala O (2004a) Increased release of cervical nitric oxide in spontaneous abortion before clinical symptoms: A possible mechanism for preabortal cervical ripening. J Clin Endocrinol Metab 89,5622-5626.
29. Väisänen-Tommiska M, Nuutila M and Ylikorkala O (2004b) Cervical nitric oxide release in women postterm. Obstet Gynecol 103,657-662.
30. Wing DA, Fassett MJ and Mishell DR (2000) Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: A randomized controlled trial. Obstet Gynecol 96,543-548.